Acura Pharmaceuticals Inc (PK)
Ticker Symbol: USOTC:ACUR
OTC Market Tier: Pink No Information
CIK Number: 0000786947
Security Type: Common Stock
ACUR Address: 616 N. North Court
Suite 120
Palatine, Illinois 60067
ACUR Country: USA
ACUR Phone: (847) 705-7709
ACUR Fax #: N/A
Website: http://www.acurapharm.com
Description: We are an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. We have discovered and developed three proprietary platform technologies which can be used to develop multiple products. Our Limitx Technology is being developed to minimize the risk of opioid overdose, our Aversion Technology is intended to address methods of abuse associated with opioid analgesics while our Impede Technology is directed at minimizing the extraction and conversion of pseudoephedrine, or PSE, into methamphetamine. Our Limitx Technology is designed to retard the release of active drug ingredients when too many tablets are accidentally or purposefully ingested by neutralizing stomach acid with buffer ingredients but deliver efficacious amounts of drug when taken as a single tablet with a nominal buffer dose. On June 28, 2019, we entered into License, Development and Commercialization Agreement with Abuse Deterrent Pharma, LLC, a Kentucky limited liability company, a special purpose company representing a consortium of investors that will finance Acura's operations and completion of development of LTX-03.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 100,000,000
Shares Outstanding: 21,300,192
Shares Outstanding Date: 10/17/2019
Shares Holder Count: 301
Shares Holder Date: 03/29/2018
Market Capitalization: $ 7,242,065.28
Key Executives: Robert Seiser - Treasurer
Bruce Wesson - Dir.
William Skelly - Dir.
Albert Brzeczko - VP, Tech. Svcs.
James Emigh - VP, Corp. Dev.
Peter Clemens - Senior VP
George Ross - Dir.
Robert Jones - CEO
Immanuel Thangaraj - Dir.
Number of Employees: 12
Incorporation State: NY
Incorporation Country: USA
Incorporation Year: 1935
Auditor: BDO USA, LLP
Auditor Address: 330 North Wabash
Suite 3200
Chicago, IL 60611
United States
Auditor Website: N/A
IR Firm: N/A
Legal Counsel: Sills Cummis & Gross, PC
Legal Counsel Address: The Legal Center
The Legal Center
Newark, NJ 07102
USA
Legal Counsel Website: http://www.sillscummis.com/
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Broadridge Financial Solutions, Inc.
TA Address: 51 Mercedes Way
Suite 1300
Philadelphia, PA 11717
USA
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 45,494
Short Date: 09/13/2019
Closing MMID: 9
BFCMmid: 6
Tier ID: 22
Status: Active


Your Recent History
USOTC
ACUR
Acura Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.